WeVote
Log In

Bill

Bill

SB 733

Relating to the creation of a medical cannabis research program; authorizing fees.

89th Legislature (2025) Introduced by José Menéndez

Texas bill establishes medical cannabis research program with fee authorization to fund scientific studies on cannabis efficacy and safety for medical applications.

Referred to Health & Human Services
#crimes--drugs(i0185) #governor(i0375) #health&humanservicescommission(v0177) #health--otherdiseases&medicalconditions(i0383) #marihuana(s3105) #medicalcannabisresearchact(po881) #medicalcannabisresearchadvisoryboard(vc6y5) #medicine&prescriptiondrugs(s7338) #occupationalregulation--healthoccupations(i0540) #physicians(s1282) #publicsafetycommission(v8707) #publicsafety #departmentof(v0251) #research&development(s0135) #stateagencies #boards&commissions--newlyproposed(i0773)
0
WeVote Research Nonpartisan
Bill Summary · SB 733

Legislative bill overview

SB 733 would establish a medical cannabis research program in Texas and authorize the collection of fees to support it. The bill enables structured scientific study of cannabis for medical purposes within the state's regulatory framework. This represents an expansion of Texas's existing limited medical cannabis access program (Compassionate Use Program).

Why is this important

Medical cannabis research could generate clinical evidence about effectiveness and safety for specific conditions, potentially informing future policy decisions about patient access. The fee structure allows the program to be self-sustaining without direct appropriation from the state budget. This positions Texas to contribute to the national body of cannabis research, which remains limited due to federal Schedule I restrictions.

Potential points of contention

  • Federal-state conflict: Cannabis remains federally illegal under Schedule I, creating legal ambiguity for researchers and institutions participating in state-authorized studies
  • Research scope and oversight: Unclear what conditions would be studied, which institutions could participate, and what safety/ethical standards would apply beyond federal requirements
  • Fee implications: The authorization to charge fees could affect accessibility of research participation and raises questions about cost distribution among patients, institutions, or general revenue

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.